கட்டுப்பாடு சோதனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கட்டுப்பாடு சோதனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கட்டுப்பாடு சோதனை Today - Breaking & Trending Today

SIRONA - The world's first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly


SIRONA - The world s first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly
SIRONA Randomized Control Trial (RCT) which compares head-to-head,
SIROlimus versus Paclitaxel Drug-Eluting Balloo
N
Angioplasty in femoropopliteal arterial diseases (SIRONA).
SIRONA is the world s first RCT investigating the use of Sirolimus drug coated balloon (DCB) (MagicTouch PTA - Concept Medical) V/S Paclitaxel DCB for the treatment of femoropopliteal artery disease.
SIRONA is an Investigator-Initiated and driven, prospective, multi-center, corelab adjudicated randomized trial to compare and evaluate the safety and efficacy of Sirolimus Coated balloon versus Paclitaxel Coated Balloon (CE certified devices) in the treatment of stenosed or occluded lesions in the superficial femoral artery (SFA), and/or popliteal artery (P1) in Peripheral Arterial Disease (PAD) patients with Rutherford classification ....

United States , Kostenloser Wertpapierhandel , Ulf Teichgr , Jena University Hospital , Prnewswire Concept Medical Inc , Medical Inc , Control Trial , Paclitaxel Drug Eluting , Sirolimus Coated , Paclitaxel Coated Balloon , Peripheral Arterial Disease , Principal Investigator , North America , Critical Limb Ischemia , Transluminal Angioplasty , Sirolimus Coated Balloon , Paclitaxel Coated , ஒன்றுபட்டது மாநிலங்களில் , ஜீனா பல்கலைக்கழகம் மருத்துவமனை , மருத்துவ இன்க் , கட்டுப்பாடு சோதனை , புற தமனி நோய் , ப்ரிந்ஸிபல் புலனாய்வாளர் , வடக்கு அமெரிக்கா ,

Golden Triangle Ventures, Inc. Technology Division Announces Successful Hemp CBD Profile Testing on its HyGrO Technology


(1)
LAS VEGAS, NV / ACCESSWIRE / March 5, 2021 / Golden Triangle Ventures, Inc. (OTC PINK:GTVH) has made significant advances through its technology division under HyFrontier Technologies, Inc. The company is currently testing its HyGrO technology on a myriad of hemp strains through a variety of applications. Recently the company has concluded an exhaustive round of studies and is pleased to announce the results of a CBD Profile test, grown with the HyGrO hydrogen water technology against a Control Test, conducted in Pueblo Colorado by Colorado Hemp Services and Halcyon Hemp.
The study was conducted with identical hemp strains that were selected at week zero of flower to be grown alongside each other. The HyFrontier Technologies hydrogen prototype watering system HyGrO was used through the remainder of flowering growth to harvest and was compared against a control group of plants of the same strains of hemp in the same location with identical conditions and growing p ....

United States , Travis Nelson , Las Vegas , Bella Estrella , John Janovec , Bessemer Bush , Wilt Chamberlain , Marilyn Monroe , Robert Dubose , Entertainment Division , Technology Division , Hyfrontier Technologies Inc , Exchange Commission , Colorado Hemp Services , Global Health Services , Golden Triangle Ventures Inc , Free Fall Testing Laboratory , Principal Of Colorado Hemp Services , Health Division , Waypoint Refinery , Golden Triangle Ventures , Hyfrontier Technologies , Control Test , Pueblo Colorado , Claremont Kind , Chunk City ,